Waters to Buy Back Stock | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today said that its board of directors has authorized the firm to repurchase up to $500 million of its outstanding common stock over the next 24 months.

The firm's previous $500 million share repurchase program, which began in February 2007, had recently expired. Waters said that that repurchase program was "substantially completed."

It said that it would make purchases of its shares through open-market transactions.

Waters' shares were trading down 1 percent at $34.70 in early Monday trade on the New York Stock Exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.